Jennifer Knight

Jennifer Knight serves as a key procurement lead within the National CMOP Office of the Department of Veterans Affairs, overseeing the acquisition of critical pharmaceuticals, diagnostic substances, and medical consumables essential to veteran healthcare. Her role centers on ensuring the secure, domestic production and reliable distribution of sovereign supply chain assets, directly supporting the agency’s mission to eliminate foreign dependency on life-saving medical inputs. She manages complex acquisitions under FAR Part 13 and Part 15 procedures, with a focus on sole-source and competitive contracting for high-integrity manufacturing capabilities. Her work ensures continuity of supply for in-vitro diagnostic agents and sterile pharmaceuticals used in VA medical facilities nationwide. Knight maintains strategic relationships with a small cohort of specialized contractors, including ALL IN SOLUTIONS LLC, ANSIBLE GOVERNMENT SOLUTIONS LLC, and INNOVATION ASSOCIATES, INC., all of which possess the technical expertise and FDA-compliant manufacturing credentials required for controlled pharmaceutical production. Her contracting patterns reflect a preference for long-term, performance-based partnerships with vendors capable of meeting stringent cGMP and DEA regulatory standards. She prioritizes vendors with proven track records in sterile compounding, radiopharmaceutical synthesis, and diagnostic reagent formulation. Her procurement strategy is heavily skewed toward small business participation, with 50% of awards designated for total small business set-asides and 37.5% reserved specifically for service-disabled veteran-owned small businesses (SDVOSBs), reflecting a deep institutional commitment to socioeconomic equity and veteran economic empowerment. Only 12.5% of acquisitions are conducted without set-asides, underscoring her proactive use of FAR 19.5 to expand market access for qualified small firms. Knight’s entire acquisition portfolio is concentrated under NAICS 325413—In-Vitro Diagnostic Substance Manufacturing—demonstrating singular expertise in procuring complex diagnostic reagents, radiolabeled compounds, and specialty pharmaceutical intermediates. Her domain knowledge spans regulatory compliance, cold-chain logistics, and biopharmaceutical quality systems, ensuring the VA’s supply chain remains resilient, secure, and mission-ready.